WHO Drug Information Vol. 25, No. 2, 2011
WHO Drug Information Vol. 25, No. 2, 2011
WHO Drug Information Vol. 25, No. 2, 2011
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>WHO</strong> <strong>Drug</strong> <strong>Information</strong> <strong>Vol</strong>. <strong>25</strong>, <strong>No</strong>. 2, <strong>2011</strong> Proposed INN: List 105fiboflaponumfiboflaponfiboflaponfiboflapón3-{3-(tert-butylsulfanyl)-1-{[4-(6-ethoxypyridin-3-yl)phenyl]methyl}-5-[(5-methylpyridin-2-yl)methoxy]-1H-indol-2-yl}-2,2-dimethylpropanoic acid5-lipoxygenase activating protein (FLAP) antagonistacide 3-{3-(tert-butylsulfanyl)-1-{[4-(6-éthoxypyridin-3-yl)phényl]méthyl}-5-[(5-méthylpyridin-2-yl)méthoxy]-1H-indol-2-yl}-2,2-diméthylpropanoïqueinhibiteur de la protéine activant la 5-lipoxygénase (FLAP)ácido 3-{3-(terc-butilsulfanil)-1-{[4-(6-etoxipiridin-3-il)fenil]metil}-5-[(5-metilpiridin-2-il)metoxi]-1H-indol-2-yl}-2,2-dimetilpropanoicoantagonista de la proteína activadora de la 5-lipoxigenasa (FLAP)C 38 H 43 N 3 O 4 S 936350-00-4H 3 CONH 3 CNCH 3CO 2 HH 3 CNOH 3 CSCH 3CH 3ficlatuzumabum #ficlatuzumabficlatuzumabimmunoglobulin G1-kappa, anti-[Homo sapiens HGF (hepatocytegrowth factor, scatter factor, SF, hepatopoeitin A)], humanizedmonoclonal antibody;gamma1 heavy chain (1-448) [humanized VH(Homo sapiens IGHV1-46*01 (82.70%) -(IGHD)-IGHJ4*01 V124>L(114)) [8.8.11] (1-118) -Homo sapiens IGHG1*03 (119-448)], (221-214')-disulfide with kappa light chain (1'-214') [humanized V-KAPPA(Homo sapiens IGKV4-1*01 (73.30%) -IGKJ2*01) [6.3.9] (1'-107') -Homo sapiens IGKC*01 (108'-214')]; (227-227":230-230")-bisdisulfide dimerimmunomodulator, antineoplasticimmunoglobuline G1-kappa, anti-[Homo sapiens HGF (facteur decroissance de l'hépatocyte, facteur dispersant, SF, hépatopoïétineA)], anticorps monoclonal humanisé;chaîne lourde gamma1 (1-448) [VH humanisé (Homo sapiensIGHV1-46*01 (82.70%) -(IGHD)-IGHJ4*01 V124>L (114)) [8.8.11](1-118) -Homo sapiens IGHG1*03 (119-448)], (221-214')-disulfureavec la chaîne légère kappa (1'-214') [V-KAPPA humanisé (Homosapiens IGKV4-1*01 (73.30%) -IGKJ2*01) [6.3.9] (1'-107') -Homosapiens IGKC*01 (108'-214')]; dimère (227-227":230-230")-bisdisulfureimmunomodulateur, antinéoplasique171